SCHEMBL3384523

SCHEMBL3384523

O=C(Cc1ccc(-c2cnc3cc(-c4ccncc4)ccn23)cc1F)Nc1cc(C(=O)N2CCOCC2)cc(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 9/20 0.46
KDR P35968 6/20 0.46
RET P07949 4/20 0.42
MKNK1 Q9BUB5 2/20 0.41
MKNK2 Q9HBH9 2/20 0.41
KCNH2 Q12809 1/20 0.39
DDR1 Q08345 2/20 0.38
DDR2 Q16832 2/20 0.38
SYK P43405 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3R1 P27986 1/20 0.38
ABL1 P00519 1/20 0.38
KIT P10721 1/20 0.38
BCR P11274 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3383251 0.88 DDR1 (0.47) FGFR3KDRRETDDR1DDR2
SCHEMBL3385512 0.87 FGFR3 (0.43) FGFR3KDRRETDDR1DDR2
SCHEMBL3385826 0.83 DDR1 (0.48) FGFR3KDRRETDDR1DDR2
SCHEMBL3384506 0.83 KDR (0.59) FGFR3KDRRETDDR1DDR2
SCHEMBL3184079 0.83 FGFR3 (0.47) FGFR3KDRRET
SCHEMBL3386457 0.82 DDR1 (0.42) FGFR3KDRRETDDR1DDR2
SCHEMBL3197078 0.80 FGFR3 (0.44) FGFR3KDRRET
SCHEMBL3385818 0.79 KDR (0.49) FGFR3KDRDDR1DDR2ABL1
SCHEMBL3384104 0.78 FGFR3 (0.46) FGFR3KDRRETDDR1DDR2
SCHEMBL3184828 0.78 KDR (0.55) FGFR3KDRDDR1DDR2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101128461-B Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors LILLY CO ELI 2010-12-22 CN disclosed
EP-1904494-B1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS LILLY CO ELI (US) 2010-12-01 EP disclosed
CN-101128461-A Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors LILLY CO ELI (US) 2008-02-20 CN disclosed